OU Receives $25 Million Grant from TSET to Expand Statewide Cancer Care OU Receives $25 Million Grant from TSET to Expand Statewide Cancer Care

OU Receives $25 Million Grant from TSET to Expand Statewide Cancer Care

The Oklahoma Tobacco Settlement Endowment Trust (TSET) has awarded the University of Oklahoma a $25 million grant to help construct a new OU Health Stephenson Cancer Center facility in Tulsa, a project that will...
OU Study Links Genetic Variants to Risk of Blinding Eye Disease in Premature Infants OU Study Links Genetic Variants to Risk of Blinding Eye Disease in Premature Infants

OU Study Links Genetic Variants to Risk of Blinding Eye Disease in Premature Infants

A new study from the University of Oklahoma suggests that small genetic differences in two proteins – previously known for their role in premature infants’ lungs – may also influence how their eyes...
GLP-1 Drugs Show Potential Anti-Cancer Effects, Review Article Finds GLP-1 Drugs Show Potential Anti-Cancer Effects, Review Article Finds

GLP-1 Drugs Show Potential Anti-Cancer Effects, Review Article Finds

The success of GLP-1 medications for treating Type 2 diabetes and obesity naturally leads to a related question: Do GLP-1 drugs affect cancer risk, which is often associated with obesity and Type 2 diabetes?
University of Oklahoma College of Dentistry, Oklahoma Dental Foundation Launch Mobile Clinic to Expand Oral Health Care in Panhandle University of Oklahoma College of Dentistry, Oklahoma Dental Foundation Launch Mobile Clinic to Expand Oral Health Care in Panhandle

University of Oklahoma College of Dentistry, Oklahoma Dental Foundation Launch Mobile Clinic to Expand Oral Health Care in Panhandle

GUYMON – As part of their mission to expand access to oral health care across Oklahoma, the University of Oklahoma College of Dentistry and the Oklahoma Dental Foundation (ODF) have launched a mobile dental...
FDA Grants Fast Track Designation to Drug Combo for Colorectal Cancer FDA Grants Fast Track Designation to Drug Combo for Colorectal Cancer

FDA Grants Fast Track Designation to Drug Combo for Colorectal Cancer

The U.S. Food and Drug Administration has granted Fast Track Designation to a new drug combination for metastatic colorectal cancer, following encouraging results from a clinical trial led in part by the University...
124678910Last